β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Blog β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceIncome Statement
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Revenue | Cost of Revenue | Gross Profit | Gross Profit Ratio | R&D Expenses | General And Administrative Expenses | Selling And Marketing Expenses | Selling General And Administrative Expenses | Other Expenses | Operating Expenses | Cost And Expenses | Interest Income | Interest Expense | Depreciation And Amortization | EBITDA | EBITDA Ratio | Operating Income | Operating Income Ratio | Total Other Income Expenses Net | Income Before Tax | Income Before Tax Ratio | Income Tax Expense | Net Income | Net Income Ratio | EPS | EPS Diluted | Weighted Average Shares Out | Weighted Average Shares Out Diluted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09 | 46138.0 | 28294.0 | 17844.0 | 0.0 | 3401.0 | 0.0 | 0.0 | 0.0 | 10563.0 | 13964.0 | 42258.0 | 0.0 | 196.0 | 3680.0 | 12152.0 | 0.26 | 3880.0 | 0.08 | 4396.0 | 8276.0 | 0.17 | 2128.0 | 6146.0 | 0.13 | 252.85 | 252.85 | 24.3 | 24.3 |
2023-09 | 40889.0 | 24374.0 | 16515.0 | 0.0 | 3184.0 | 0.0 | 0.0 | 8331.0 | 1142.0 | 12657.0 | 37031.0 | 0.0 | 121.0 | 3023.0 | 7543.0 | 0.18 | 3858.0 | 0.09 | 541.0 | 4399.0 | 0.1 | 963.0 | 3435.0 | 0.08 | 141.35 | 141.35 | 24.3 | 24.3 |
2022-09 | 35426.0 | 20867.0 | 14559.0 | 0.0 | 2485.0 | 0.0 | 0.0 | 7355.0 | 8292.0 | 10777.0 | 31644.0 | 34.0 | 77.0 | 2745.0 | 6523.0 | 0.19 | 3777.0 | 0.1 | -54.0 | 3723.0 | 0.1 | 1026.0 | 2696.0 | 0.07 | 110.98 | 110.98 | 24.29 | 24.29 |
2021-09 | 33990.0 | 19239.0 | 14751.0 | 0.0 | 2446.0 | 0.0 | 1345.0 | 1345.0 | 7607.0 | 11398.0 | 30637.0 | 46.0 | 53.0 | 2106.0 | 5455.0 | 0.15 | 3349.0 | 0.09 | 22.0 | 3371.0 | 0.09 | 938.0 | 2432.0 | 0.07 | 90.52 | 90.52 | 26.86 | 26.86 |
2020-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-09 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Discover additional income statement data for Fuji Pharma!
Sign up for free or log in
Have you heard about our short Daily Video Newsletter?
Find out more